These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 24284101

  • 1. Porphyrins as urinary biomarkers for bladder cancer after 5-aminolevulinic acid (ALA) administration: the potential of photodynamic screening for tumors.
    Inoue K, Ota U, Ishizuka M, Kawada C, Fukuhara H, Shuin T, Okura I, Tanaka T, Ogura S.
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):484-9. PubMed ID: 24284101
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - a prospective audit.
    Ahmad S, Aboumarzouk O, Somani B, Nabi G, Kata SG.
    BJU Int; 2012 Dec; 110(11 Pt B):E596-600. PubMed ID: 22758907
    [Abstract] [Full Text] [Related]

  • 4. Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer.
    Inoue K, Fukuhara H, Shimamoto T, Kamada M, Iiyama T, Miyamura M, Kurabayashi A, Furihata M, Tanimura M, Watanabe H, Shuin T.
    Cancer; 2012 Feb 15; 118(4):1062-74. PubMed ID: 21773973
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Urinary 5-Aminolevulinic Acid Concentrations as a Potential Tumor Marker for Colorectal Cancer Screening and Recurrence.
    Kamada Y, Murayama Y, Ota U, Takahashi K, Arita T, Kosuga T, Konishi H, Morimura R, Komatsu S, Shiozaki A, Kuriu Y, Ikoma H, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Tanaka T, Otsuji E.
    Anticancer Res; 2016 May 15; 36(5):2445-50. PubMed ID: 27127156
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Excretion of porphyrins in urine and bile after the administration of delta-aminolevulinic acid.
    Shimizu Y, Ida S, Naruto H, Urata G.
    J Lab Clin Med; 1978 Nov 15; 92(5):795-802. PubMed ID: 712211
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of efficiency of photodynamic diagnostics with topical use of the 3% and 15% aminolevulinic acid in the detection of vulvar lesions.
    Maździarz A, Zielińska A, Alkhalayla H, Spiewankiewicz B.
    Photodiagnosis Photodyn Ther; 2013 Dec 15; 10(4):422-8. PubMed ID: 24284095
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo.
    Hua Z, Gibson SL, Foster TH, Hilf R.
    Cancer Res; 1995 Apr 15; 55(8):1723-31. PubMed ID: 7712481
    [Abstract] [Full Text] [Related]

  • 13. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q, Warloe T, Moan J, Godal A, Apricena F, Giercksky KE, Nesland JM.
    Cancer Res; 2001 Aug 01; 61(15):5824-32. PubMed ID: 11479222
    [Abstract] [Full Text] [Related]

  • 14. Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors.
    Burger M, Stief CG, Zaak D, Stenzl A, Wieland WF, Jocham D, Otto W, Denzinger S.
    Urology; 2009 Dec 01; 74(6):1282-6. PubMed ID: 19819538
    [Abstract] [Full Text] [Related]

  • 15. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence.
    Kriegmair M, Baumgartner R, Knüchel R, Stepp H, Hofstädter F, Hofstetter A.
    J Urol; 1996 Jan 01; 155(1):105-9; discussion 109-10. PubMed ID: 7490803
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Intraoperative photodynamic diagnosis for spinal ependymoma using 5-aminolevulinic acid: technical note].
    Arai T, Tani S, Isoshima A, Nagashima H, Joki T, Takahashi-Fujigasaki J, Abe T.
    No Shinkei Geka; 2006 Aug 01; 34(8):811-7. PubMed ID: 16910494
    [Abstract] [Full Text] [Related]

  • 18. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study.
    Denzinger S, Burger M, Walter B, Knuechel R, Roessler W, Wieland WF, Filbeck T.
    Urology; 2007 Apr 01; 69(4):675-9. PubMed ID: 17445650
    [Abstract] [Full Text] [Related]

  • 19. Photodynamic diagnosis using 5-aminolevulinic acid during gastrectomy for gastric cancer.
    Namikawa T, Inoue K, Uemura S, Shiga M, Maeda H, Kitagawa H, Fukuhara H, Kobayashi M, Shuin T, Hanazaki K.
    J Surg Oncol; 2014 Mar 01; 109(3):213-7. PubMed ID: 24214406
    [Abstract] [Full Text] [Related]

  • 20. Spectrophotometric photodynamic detection involving extracorporeal treatment with hexaminolevulinate for bladder cancer cells in voided urine.
    Nakai Y, Ozawa T, Mizuno F, Onishi S, Owari T, Hori S, Morizawa Y, Tatsumi Y, Miyake M, Tanaka N, Tsuruta D, Fujimoto K.
    J Cancer Res Clin Oncol; 2017 Nov 01; 143(11):2309-2316. PubMed ID: 28726046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.